DEFINITIONS.

62J.86 DEFINITIONS. § Subdivision 1.Definitions. For the purposes of sections 62J.85 to 62J.95, the following terms have the meanings given. § Subd. 2.Advisory council. "Advisory council" means the Prescription Drug Affordability Advisory Council established under section 62J.88. § Subd. 3.Biologic. "Biologic" means a drug that is produced or distributed in accordance with a biologics license application approved under Code of Federal Regulations, title 42, section 447.502. § Subd. 4.Biosimilar. "Biosimilar" has the meaning provided in section 62J.84, subdivision 2, paragraph (b). § Subd. 5.Board. "Board" means the Prescription Drug Affordability Board established under section 62J.87. § Subd. 6.Brand name drug. "Brand name drug" means a drug that is produced or distributed pursuant to: (1) a new drug application approved under United States Code, title 21, section 355(c), except for a generic drug as defined under Code of Federal Regulations, title 42, section 447.502; or (2) a biologics license application approved under United States Code, title 45, section 262(a)(c). § Subd. 7.Generic drug. "Generic drug" has the meaning provided in section 62J.84, subdivision 2, paragraph (e). § Subd. 8.Group purchaser. "Group purchaser" has the meaning given in section 62J.03, subdivision 6, and includes pharmacy benefit managers, as defined in section 62W.02, subdivision 15. § Subd. 9.Manufacturer. "Manufacturer" means an entity that: (1) engages in the manufacture of a prescription drug product or enters into a lease with another manufacturer to market and distribute a prescription drug product under the entity's own name; and (2) sets or changes the wholesale acquisition cost of the prescription drug product it manufacturers or markets. § Subd. 10.Prescription drug product. "Prescription drug product" means a brand name drug, a generic drug, a biologic, or a biosimilar. § Subd. 11.Wholesale acquisition cost or WAC. "Wholesale acquisition cost" or "WAC" has the meaning given in United States Code, title 42, section 1395W-3a(c)(6)(B). History: 2023 c 57 art 2 s 29